Harrow Health Inc (HROW) stock news · rev $272.3M
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
This HROW news page leads with what Harrow Health Inc filed — not a scraped headline mill.
No cached 8-K sentence for HROW yet. We will not pad this page with generic market recap.
Latest reported HROW revenue for 2025-12-31 was $272.3M. Net income was -$5.1M. Revenue was up 36.4% from 2024-12-31 to 2025-12-31. HROW currently screens at market cap $1.28B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the HROW stock page; for the tape open the quote page.
HROW stock news FAQ
What are HROW's latest revenue and net income?
Latest cached Harrow Health Inc (HROW) revenue for Dec 31, 2025 was $272.3M. Net income was -$5.1M. Statements: https://lician.com/financials/hrow
How did HROW revenue change from the prior cached period?
Cached Harrow Health Inc (HROW) revenue was up 36.4% from $199.6M (Dec 31, 2024) to $272.3M (Dec 31, 2025). Statements: https://lician.com/financials/hrow
What is HROW's market cap?
Harrow Health Inc (HROW) market cap is $1.28B on the latest cached fundamentals snapshot.
What kind of company is HROW?
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Where is HROW stock news listed?
Cached stock news for Harrow Health Inc (HROW) is listed at https://lician.com/news/hrow. Filings: https://lician.com/sec/hrow
Not investment advice.